RheinBio announced that net profit for the first half of 2026 is expected to be 495.43 million yuan to 609.76 million yuan, an increase of 30% to 60% over the previous year. The main reason is that, on the one hand, the company continues to improve product quality, enhance customer stickiness, and promote steady year-on-year revenue growth; on the other hand, the company continuously optimizes its product structure, and its comprehensive gross margin has recovered to a certain extent compared to the same period last year. The year-on-year increase in revenue and the improvement in gross profit simultaneously drove the company's performance in the reporting period to achieve higher growth.

RheinBio announced that net profit for the first half of 2026 is expected to be 495.43 million yuan to 609.76 million yuan, an increase of 30% to 60% over the previous year. The main reason is that, on the one hand, the company continues to improve product quality, enhance customer stickiness, and promote steady year-on-year revenue growth; on the other hand, the company continuously optimizes its product structure, and its comprehensive gross margin has recovered to a certain extent compared to the same period last year. The year-on-year increase in revenue and the improvement in gross profit simultaneously drove the company's performance in the reporting period to achieve higher growth.